BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8729206)

  • 21. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 23. Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism.
    Bruinsma N; Willems RJ; van den Bogaard AE; van Santen-Verheuvel M; London N; Driessen C; Stobberingh EE
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2779-83. PubMed ID: 12183228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium.
    Vankerckhoven V; Van Autgaerden T; Vael C; Lammens C; Chapelle S; Rossi R; Jabes D; Goossens H
    J Clin Microbiol; 2004 Oct; 42(10):4473-9. PubMed ID: 15472296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
    Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
    PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin resistance and mortality associated with enterococcal bacteremia.
    Lautenbach E; Brennan PJ
    Clin Infect Dis; 1997 Mar; 24(3):530-1. PubMed ID: 9114224
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
    Mekonen ET; Noskin GA; Hacek DM; Peterson LR
    Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
    Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
    Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
    Mainous MR; Lipsett PA; O'Brien M
    Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
    Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
    Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.
    Dominguez EA; Davis JC; Langnas AN; Winfield B; Cavalieri SJ; Rupp ME
    Liver Transpl Surg; 1997 Nov; 3(6):586-90. PubMed ID: 9404957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.
    Moemen D; Tawfeek D; Badawy W
    Braz J Microbiol; 2015; 46(3):777-83. PubMed ID: 26413060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.
    Edmond MB; Ober JF; Weinbaum DL; Pfaller MA; Hwang T; Sanford MD; Wenzel RP
    Clin Infect Dis; 1995 May; 20(5):1126-33. PubMed ID: 7619987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and genotypic characterization of vancomycin-resistant Enterococcus faecium clinical isolates from two hospitals in Mexico: First detection of VanB phenotype-vanA genotype.
    Bocanegra-Ibarias P; Flores-Treviño S; Camacho-Ortiz A; Morfin-Otero R; Villarreal-Treviño L; Llaca-Díaz J; Martínez-Landeros EA; Rodríguez-Noriega E; Calzada-Güereca A; Maldonado-Garza HJ; Garza-González E
    Enferm Infecc Microbiol Clin; 2016; 34(7):415-21. PubMed ID: 26589756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
    Roghmann MC; Qaiyumi S; Johnson JA; Schwalbe R; Morris JG
    Clin Infect Dis; 1997 Mar; 24(3):514-5. PubMed ID: 9114211
    [No Abstract]   [Full Text] [Related]  

  • 38. The rise in vancomycin-resistant
    Markwart R; Willrich N; Haller S; Noll I; Koppe U; Werner G; Eckmanns T; Reuss A
    Antimicrob Resist Infect Control; 2019; 8():147. PubMed ID: 31485325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
    Yoon YK; Lee SE; Lee J; Kim HJ; Kim JY; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1831-8. PubMed ID: 21652622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.